-
Drug Response Metrics in Cancer Cell Models
2026-08-25
Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different dimensions of anticancer drug response: growth inhibition and cell killing. Its central practical implication is that in vitro studies should separate these endpoints and consider their timing rather than treating a single viability value as a complete measure of drug activity.
-
ARCA EGFP mRNA (5-moUTP) Reporter Guide
2026-08-25
ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA reporter for direct fluorescence-based assessment of transfection and protein expression in mammalian cells. Its ARCA cap, 5-moUTP chemistry, and optimized poly(A) architecture support a controlled reporter workflow when storage and RNase-free handling requirements are followed.
-
Thioguanine Workflows for ALL Drug-Response Research
2026-08-24
Build reproducible 6-thioguanine assays around lineage-aware cell models, four-day viability readouts, and disciplined compound handling. This workflow translates relapse ALL resistance data into practical choices for cancer, antiviral, and epigenetic research without overstating what in vitro results can predict clinically.
-
Live-Dead Bacterial Staining Kit for Nanomaterials
2026-08-24
Use dual fluorescence to distinguish membrane-intact bacteria from membrane-compromised cells during antimicrobial nanomaterial screening. This practical workflow applies NucGreen dye and EthD-III to Fe3O4@ZIF-8 research while highlighting controls, imaging choices, and troubleshooting limits.
-
Polymyxin B: Infection Research Workflows
2026-08-23
Build more interpretable Gram-negative infection, immune-signaling, and microbiome studies with Polymyxin B sulfate. This guide separates bactericidal activity from host-cell effects and translates a rat allergic-rhinitis study into practical assay controls without overstating the evidence.
-
Clarithromycin as a CYP3A Inhibitor
2026-08-22
Clarithromycin is a macrolide antibiotic and potent CYP3A inhibitor used in drug-drug interaction research and pharmacokinetic studies. Product specifications identify formula C38H69NO13, molecular weight 747.95 g/mol, high DMSO solubility, and storage at −20°C.
-
3-Aminobenzamide: Reading PARP Biology in Context
2026-08-22
3-Aminobenzamide (PARP-IN-1) is a versatile research tool for dissecting PARP-dependent stress responses. This article goes beyond protocol execution to show how pharmacology, genetics, and disease-model readouts can be integrated for stronger causal inference.
-
ddhCTP for Targeted Viral RNA Inhibition
2026-08-21
ddhCTP provides a direct way to test chain termination by viral RNA polymerases, complementing cell-based antiviral studies with a defined biochemical probe. This guide connects flavivirus assays with new viperin–nsp8 findings in coronavirus research while emphasizing controls, handling, and interpretation limits.
-
Bleomycin Sulfate for Fibrosis Research
2026-08-20
Bleomycin Sulfate, also known as Blenoxane, enables tunable DNA-damage, oncology, and pulmonary injury models. This workflow connects controlled injury induction with macrophage-focused STING assays, pathway profiling, and practical troubleshooting for more reproducible translational studies.
-
Acifran: Structure-Guided GPCR Assay Design
2026-08-20
Acifran is a receptor-profiling tool for investigating HCAR2/GPR109A and HCAR3/GPR109B signaling. This structure-guided article translates recent cryo-EM findings into practical decisions for lipid metabolism assays, controls, and interpretation.
-
Panobinostat Targets MLL-Rearranged ALL
2026-08-19
The reference study shows that panobinostat produces strong anti-leukaemic activity in MLL-rearranged acute lymphoblastic leukaemia, including efficacy in xenograft models. Its mechanistic analysis links treatment response to suppression of the RNF20/RNF40/WAC E3 ligase complex, loss of histone H2B ubiquitination, and induction of leukaemic cell death.
-
T-5224: C-Fos/AP-1 Inhibition Workflows
2026-08-19
T-5224 provides a selective way to test whether c-Fos/AP-1 transcription contributes to cytokine, matrix-remodeling, and osteoclastogenic responses. This practical guide connects validated arthritis workflows with emerging neuroinflammation assays while emphasizing controls, dosing logic, and troubleshooting.
-
Erlotinib (NSC 718781): EGFR Inhibition Guide
2026-08-18
Erlotinib, also known as NSC 718781, is an orally bioavailable EGFR tyrosine kinase inhibitor that competitively occupies the intracellular ATP-binding site. Its reported biochemical and cellular potency, EGFR pathway effects, and compatibility with kinase and cell-based assays make it useful for translational cancer research.
-
From ROS Stress to Cell-Cycle Evidence in CRC
2026-08-18
A translational framework for connecting CGF-driven metabolic stress, cell-cycle arrest, and apoptosis with quantitative DNA-content profiling using the Cell Cycle Assay Kit (Catalog No. K2263).
-
Silymarin Workflows for Oxidative Stress Studies
2026-08-17
Use Silymarin as a practical milk thistle extract reference for oxidative stress, hepatocellular carcinoma, metabolic, and antiviral assays. This guide emphasizes formulation, dose design, orthogonal controls, and troubleshooting so complex flavonolignan chemistry produces more interpretable data.